Literature DB >> 3949385

Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin.

M A Freudenberg, D Keppler, C Galanos.   

Abstract

Injection of D-galactosamine sensitizes mice many thousand-fold to the lethal action of endotoxin (lipopolysaccharide [LPS]). Comparable sensitization was practically absent in LPS-resistant C3H/HeJ mice, which after D-galactosamine treatment were about 500,000 times less sensitive to LPS lethality than histocompatible LPS-sensitive C3H/HeN mice. D-Galactosamine induces changes in the hepatocytes of treated animals, such as depletion of UTP and alterations in the pattern of UDP sugars. These early biochemical changes, which are necessary for development of sensitization, were similar in both mouse strains which we examined. High sensitivity to the lethal effects of LPS was achieved in C3H/HeJ mice after D-galactosamine treatment by transfer of C3H/HeN macrophages obtained in culture from bone marrow precursor cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3949385      PMCID: PMC260982          DOI: 10.1128/iai.51.3.891-895.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Characterization of the effects of endotoxin on macrophage tumor cell killing.

Authors:  J B Weinberg; H A Chapman; J B Hibbs
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

2.  Failure of endotoxin to increase nonspecific resistance to infection of lipopolysaccharide low-responder mice.

Authors:  L Chedid; M Parant; C Damais; F Parant; D Juy; A Galelli
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

3.  Macrophage activation for tumor cytotoxicity: tumoricidal activity by macrophages from C3H/HeJ mice requires at least two activation stimuli.

Authors:  L P Ruco; M S Meltzer
Journal:  Cell Immunol       Date:  1978-11       Impact factor: 4.868

Review 4.  The effects of bacterial endotoxins on host mediation systems. A review.

Authors:  D C Morrison; R J Ulevitch
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

5.  Induction of hyperreactivity to endotoxin in mice by Coxiella burnetii.

Authors:  S Schramek; J Kazar; Z Sekeyova; M A Freudenberg; C Galanos
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

6.  Preparation and properties of a standardized lipopolysaccharide from salmonella abortus equi (Novo-Pyrexal).

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Zentralbl Bakteriol Orig A       Date:  1979-04

7.  Defective tumoricidal capacity of macrophages from C3H/HeJ mice.

Authors:  L P Ruco; M S Meltzer
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

8.  Galactosamine-induced sensitization to the lethal effects of endotoxin.

Authors:  C Galanos; M A Freudenberg; W Reutter
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

9.  BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. I. In vivo studies.

Authors:  S N Vogel; R N Moore; J D Sipe; D L Rosenstreich
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

10.  The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxim.

Authors:  S M Michalek; R N Moore; J R McGhee; D L Rosenstreich; S E Mergenhagen
Journal:  J Infect Dis       Date:  1980-01       Impact factor: 5.226

View more
  91 in total

1.  Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation.

Authors:  A Poltorak; P Ricciardi-Castagnoli; S Citterio; B Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

Review 2.  Bloodstream infections: epidemiology, pathophysiology and therapeutic perspectives.

Authors:  R Salomão; O Rigato; A C Pignatari; M A Freudenberg; C Galanos
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

Review 3.  The biology of endotoxin.

Authors:  H Heine; E T Rietschel; A J Ulmer
Journal:  Mol Biotechnol       Date:  2001-11       Impact factor: 2.695

4.  Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice.

Authors:  M A Freudenberg; C Galanos
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

5.  Dexamethasone attenuates staphylococcal enterotoxin B-induced hypothermic response and protects mice from superantigen-induced toxic shock.

Authors:  Teresa Krakauer; Marilyn Buckley
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

6.  [Lipopolysaccharides, endotoxins and O-antigens of gram-negative bacteria: chemical structure, biologic effect and serologic properties].

Authors:  E T Rietschel; H Brade
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

Review 7.  Neurobiology of resilience in depression: immune and vascular insights from human and animal studies.

Authors:  Katarzyna A Dudek; Laurence Dion-Albert; Fernanda Neutzling Kaufmann; Ellen Tuck; Manon Lebel; Caroline Menard
Journal:  Eur J Neurosci       Date:  2019-09-13       Impact factor: 3.386

8.  Resilience to bacterial infection: difference between species could be due to proteins in serum.

Authors:  H Shaw Warren; Catherine Fitting; Eva Hoff; Minou Adib-Conquy; Laura Beasley-Topliffe; Brenda Tesini; Xueya Liang; Catherine Valentine; Judith Hellman; Douglas Hayden; Jean-Marc Cavaillon
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

9.  Activated macrophages depress the contractility of rabbit carotids via an L-arginine/nitric oxide-dependent effector mechanism. Connection with amplified cytokine release.

Authors:  C Bernard; B Szekely; I Philip; E Wollman; D Payen; A Tedgui
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

10.  The effect of endotoxin on membrane fatty acid composition in BCG-sensitized mice.

Authors:  J M Stark; S K Jackson; S Taylor; I Davies; J L Harwood
Journal:  Experientia       Date:  1990-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.